curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Validation of the Turkish Version of the S3-NIV Questionnaire

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Respiratory Insufficiency; Chronic Respiratory Failure Interventions: Other: Turkish Version of the S3-NIV Questionnaire Sponsors: Istanbul Saglik Bilimleri University Not yet recruiting Conditions: Respiratory Insufficiency; Chronic Respiratory Failure...

Multimodal MRI Study of Acupuncture’s Rapid Antidepressant Mechanisms and Response Prediction in Depression

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Major Depressive Disorder Interventions: Procedure: Acupuncture; Procedure: Sham Acupuncture Sponsors: Second Affiliated Hospital of Tsinghua University Not yet recruiting Conditions: Major Depressive Disorder Interventions: Procedure: Acupuncture;...

Observational Study of Electrical Impedance Tomography for Non-Invasive Assessment of Cerebral Autoregulation in Neurocritical Patients

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Homeostasis Interventions: Other: Non-invasive cerebral Electrical Impedance Tomography (EIT) monitoring Sponsors: Xijing Hospital Not yet recruiting Conditions: Homeostasis Interventions: Other: Non-invasive cerebral Electrical Impedance Tomography...

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Biological: Administration of CAR T-cells at 3 different dose levels Sponsors: Kure Cells, INC; CellServe LLC; Roya Clinical Not yet recruiting Conditions: Multiple Myeloma in...

Real-World Patterns of Utilization of Lenalidomide-based Triplet Regimens in FIrst RElapsed Multiple Myeloma Patients: Evidence From Medical Record Review

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Completed Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia...
« Older Entries
Next Entries »

Recent Posts

  • A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
  • Determination 2 – Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
  • Feasibility of a Community-Based Multimodal Exercise Programme in Parkinson’s Disease
  • cRCT of AI Agent in Clinital Resoning Training
  • Imaging CRF X NOP Interactions in Alcohol Use Disorder

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®